NVIDIA
NVDA
Tesla
TSLA
Applovin
APP
4
Alibaba
BABA
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
KYTX Kyverna Therapeutics
- 2.820
- -0.080-2.76%
Close Feb 26 16:00 ET
- 2.980
- +0.160+5.67%
Post 19:29 ET
121.74MMarket Cap-1.10P/E (TTM)
3.030High2.805Low219.36KVolume2.870Open2.900Pre Close635.53KTurnover0.98%Turnover RatioLossP/E (Static)43.17MShares30.60052wk High0.40P/B63.09MFloat Cap2.64552wk Low--Dividend TTM22.37MShs Float35.060Historical High--Div YieldTTM7.76%Amplitude2.645Historical Low2.897Avg Price1Lot Size
Kyverna Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -146.94%-27.49M | -114.76%-24.18M | -122.77%-25.53M | -45.13%-52.41M | -110.54%-18.56M | -11.13M | -11.26M | -11.46M | -63.00%-36.11M | -8.82M |
| Net income from continuing operations | -123.03%-34.49M | -120.02%-28.8M | -139.55%-26.69M | -108.93%-60.37M | -143.26%-20.67M | ---15.47M | ---13.09M | ---11.14M | -9.65%-28.89M | ---8.5M |
| Depreciation and amortization | 27.40%558K | 28.33%530K | 22.34%482K | 62.42%1.71M | 23.53%462K | --438K | --413K | --394K | 79.35%1.05M | --374K |
| Other non cash items | 51.35%672K | 50.91%661K | 36.98%526K | 21.90%1.72M | 8.35%454K | --444K | --438K | --384K | 70.21%1.41M | --419K |
| Change In working capital | 55.88%5.25M | 734.85%4.41M | -23.94%-1.84M | 133.16%3.42M | 176.91%1.01M | --3.37M | --528K | ---1.48M | -129.95%-10.33M | ---1.31M |
| -Change in prepaid assets | -273.55%-1.2M | 521.14%3.11M | -1,498.14%-2.57M | -31.13%-1.19M | -207.81%-985K | --692K | ---738K | ---161K | -25.90%-909K | ---320K |
| -Change in payables and accrued expense | 126.06%7.44M | 72.72%1.95M | 383.52%1.55M | 908.85%5.48M | 133.87%1.61M | --3.29M | --1.13M | ---546K | -131.46%-678K | --688K |
| -Change in other current assets | -283.24%-663K | -106.83%-39K | 32.64%-293K | -190.27%-1.85M | -214.58%-1.81M | ---173K | --571K | ---435K | -1,533.33%-637K | ---576K |
| -Change in other current liabilities | 26.30%-325K | -40.78%-611K | -52.49%-520K | 191.00%981K | 367.27%2.2M | ---441K | ---434K | ---341K | -372.81%-1.08M | ---822K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -24.18%-7.03M | ---282K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -146.94%-27.49M | -114.76%-24.18M | -122.77%-25.53M | -45.13%-52.41M | -110.54%-18.56M | ---11.13M | ---11.26M | ---11.46M | -63.00%-36.11M | ---8.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 101.25%676K | -2,263,933.33%-67.92M | -999.88%-122.88M | 37.68%-8.79M | 109.16%31.68M | -54.12M | -3K | 13.66M | -993.64%-14.1M | 15.15M |
| Net PPE purchase and sale | 60.16%-102K | -34,166.67%-1.03M | -1,839.29%-543K | 19.14%-621K | -2,683.33%-334K | ---256K | ---3K | ---28K | 40.42%-768K | ---12K |
| Net investment purchase and sale | 101.44%778K | ---66.89M | -994.07%-122.34M | 38.75%-8.16M | 111.19%32.02M | ---53.86M | --0 | --13.68M | ---13.33M | --15.16M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 101.25%676K | -2,263,933.33%-67.92M | -999.88%-122.88M | 37.68%-8.79M | 109.16%31.68M | ---54.12M | ---3K | --13.66M | -993.64%-14.1M | --15.15M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.44%-152K | -102.28%-569K | 234,856.25%338.05M | 389.21%58.12M | -1,305.88%-1.43M | 34.79M | 24.91M | -144K | -83.62%11.88M | -102K |
| Net issuance payments of debt | -18.05%-242K | -24.87%-236K | -37.50%-231K | -213.65%-781K | -51.03%-219K | ---205K | ---189K | ---168K | -507.32%-249K | ---145K |
| Net common stock issuance | --0 | --0 | --341.17M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net preferred stock issuance | --0 | ---- | ---- | 401.09%59.9M | --0 | --34.84M | ---- | ---- | -83.52%11.95M | --0 |
| Proceeds from stock option exercised by employees | -70.97%90K | 102.78%73K | 166.67%64K | 268.57%645K | 539.53%275K | --310K | --36K | --24K | 483.33%175K | --43K |
| Net other financing activities | --0 | ---406K | ---2.96M | ---1.65M | ---1.49M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.44%-152K | -102.28%-569K | 234,856.25%338.05M | 389.21%58.12M | -1,305.88%-1.43M | --34.79M | --24.91M | ---144K | -83.62%11.88M | ---102K |
| Net cash flow | ||||||||||
| Beginning cash position | 144.85%132.19M | 457.38%224.86M | -8.04%35.21M | -50.03%38.29M | -26.61%23.53M | --53.99M | --40.34M | --38.29M | 178.21%76.62M | --32.06M |
| Current changes in cash | 11.47%-26.97M | -779.06%-92.67M | 9,137.46%189.65M | 91.97%-3.08M | 87.60%11.68M | ---30.46M | --13.65M | --2.05M | -178.10%-38.33M | --6.23M |
| End cash Position | 347.24%105.23M | 144.85%132.19M | 457.38%224.86M | -8.04%35.21M | -8.04%35.21M | --23.53M | --53.99M | --40.34M | -50.03%38.29M | --38.29M |
| Free cash flow | -142.28%-27.59M | -123.83%-25.2M | -126.95%-26.07M | -43.79%-53.03M | -114.03%-18.9M | ---11.39M | ---11.26M | ---11.49M | -57.32%-36.88M | ---8.83M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |